Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Elena, Karnaukhova"'
Autor:
Rishisree, Achanta, Mallory, Brayer, Elena, Karnaukhova, Teodora, Jankovic, Gordana, Zdunić, Katarina, Šavikin, Aleksandar, Jeremic
Publikováno v:
In Biophysical Chemistry January 2024 304
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Introduction Protease activated receptors 1 (PAR1) and 4 (PAR4) agonists are used to study platelet activation. Data on platelet activation are extrapolated across experimental settings. C1-inhibitor (C1INH) is a protease inhibitor present in plasma
Externí odkaz:
https://doaj.org/article/c02ef28fa6884a4193916003ebf2cc9d
Publikováno v:
Journal of Thrombosis and Thrombolysis. 55:566-570
Autor:
Haarin Chun, James H. Kurasawa, Philip Olivares, Ekaterina S. Marakasova, Svetlana A. Shestopal, Gabriela U. Hassink, Elena Karnaukhova, Mary Migliorini, Juliet O. Obi, Ally K. Smith, Patrick L. Wintrode, Prasannavenkatesh Durai, Keunwan Park, Daniel Deredge, Dudley K. Strickland, Andrey G. Sarafanov
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:2255-2269
Deficiency in blood coagulation factor VIII (FVIII) results in life-threating bleeding (hemophilia A) treated by infusions of FVIII concentrates. To improve disease treatment, FVIII has been modified to increase its plasma half-life, which requires u
Autor:
Elena Karnaukhova
Publikováno v:
Current Medicinal Chemistry. 29:467-488
Human C1-Inhibitor (C1INH), also known as C1-esterase inhibitor, is an important multifunctional plasma glycoprotein that is uniquely involved in a regulatory network of complement, contact, coagulation, and fibrinolytic systems. C1INH belongs to a s
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 3, p 1199 (2021)
Plasma hemopexin (HPX) is the key antioxidant protein of the endogenous clearance pathway that limits the deleterious effects of heme released from hemoglobin and myoglobin (the term “heme” is used in this article to denote both the ferrous and f
Externí odkaz:
https://doaj.org/article/125e8a51015d4bb69b2df2d2cd77b99f
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports
Scientific Reports
Animal models of hemostasis are often extrapolated to humans; however, only a few studies have compared coagulation and fibrinolysis across species. Simultaneous thrombin (TG) and plasmin (PG) generation is useful to assessing coagulation and fibrino
Publikováno v:
Journal of Thrombosis and Thrombolysis. 48:81-87
C1-inhibitor (C1INH) was shown to enhance thrombin generation (TG) in the presence of thrombomodulin (TM) by reducing production of activated protein C. Because C1INH is known to inhibit fibrinolytic system proteases, the objective of this study was
Publikováno v:
Thrombosis Research. 176:54-60
Package inserts for C1-esterase inhibitor (C1INH) products include warnings for an elevated risk of possible thrombosis in certain individuals, referring to thromboembolic events (TEEs) that were reported to occur after C1INH infusions. However, the
Autor:
Zhao-Hua Zhou, Elena Karnaukhova, Mohsen Rajabi, Kelly Reeder, Trina Chen, Subhash Dhawan, Steven Kozlowski
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94402 (2014)
Oversulfated chondroitin sulfate (OSCS), a member of the glycosaminoglycan (GAG) family, was a contaminant in heparin that was linked to the 2008 heparin adverse events in the US. Because of its highly negative charge, OSCS can interact with many com
Externí odkaz:
https://doaj.org/article/bf52e2532ef541c280f9251f6a9b4dfd